125
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Association of prostate volume with incidence and aggressiveness of prostate cancer

, , &
Pages 201-205 | Published online: 26 Oct 2016

References

  • LeporHPathophysiology, epidemiology, and natural history of benign prostatic hyperplasiaRev Urol20046suppl 9S3S10
  • Al-KhalilSBootheDDurdinTPossible interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostatesInt Urol Nephrol2016481919726590832
  • BoschJLHopWCKirkelsWJSchröderFHThe international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate, and residual urine volumeBr J Urol19957556226307542132
  • SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
  • GosselaarCRoobolMJRoemelingSEuropean Randomized Study of Screening for Prostate Cancer (ERSPC)Screening for prostate cancer without digital rectal examination and transrectal ultrasound: results after four years in the European Randomized Study of Screening for Prostate Cancer (ERSPC), RotterdamProstate200666662563116388507
  • KimJSRyuJGKimJWProstate-specific antigen fluctuation: what does it mean in diagnosis of prostate cancer?Int Braz J Urol201541225826426005966
  • De GorskiARoupretMPeyronnetBAccuracy of magnetic resonance imaging/ultrasound fusion targeted biopsies to diagnose clinically significant prostate cancer in enlarged compared to smaller prostatesJ Urol2015194366967325784374
  • LevineMAIttmanMMelamedJLeporHTwo consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancerJ Urol199815924714769649265
  • ChenMETroncosoPJohnstonDProstate cancer detection: relationship to prostate sizeUrology199953476476810197853
  • OhJJJeongSJJeongCWIs there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?Prostate2013731424722585359
  • FreedlandSJIsaacsWBPlatzEAProstate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database studyJ Clin Oncol200523307546755416234520
  • FilsonCMargolisDHuangJMR-US fusion biopsy: importance of both systematic and targeted sampling to diagnose prostate cancerAmerican Urological Association Annual MeetingMay 15, 2015New Orleans, LA
  • UngJOSan FranciscoIFReganMMDeWolfWCOlumiAFThe relationship of prostate gland volume to extended needle biopsy on prostate cancer detectionJ Urol2003169113013512478120
  • KozminskiMAPalapattuGSMehraRUnderstanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancerUrology201484237337824958484
  • HongSKPoonBYSjobergDDProstate size and adverse pathologic features in men undergoing radical prostatectomyUrology201484115315724976228
  • WeraheraPNSullivanKLa RosaFGOptimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volumeInt J Clin Exp Pathol20125989289923119106
  • YoonBIShinTSChoHJIs it effective to perform two more prostate biopsies according to prostate-specific antigen level and prostate volume in detecting prostate cancer? Prospective study of 10-core and 12-core prostate biopsyUrol J20129249149722641493
  • MarksLSRoehrbornCGWolfordEWilsonTHThe effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment responseJ Urol200717741408141317382742
  • AyalaAGRoJYBabaianRTroncosoPGrignonDJThe prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinomaAm J Surg Pathol198913121272909195